Jun 30, 2020
COVID-19 : : Osteoporosis Drug Proves Effective Against Coronavirus
This news has been received from: cvbj.biz
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
Scientific studies to find effective vaccines and treatments for coronavirus continue to advance. The information on the disease that the institutions that carry out these tasks have has increased over the months and possible solutions to combat the symptoms it causes are beginning to be known.
In this sense, the European Commission (EC) has offered hopeful news by revealing in a statement that A generic drug used to fight osteoporosis “could serve as a positive treatment for COVID-19 positive patients with mild or asymptomatic symptoms.” Said drug is called Raloxifene.
The research about the efficacy of this medicine in the face of the new ailment that has spread throughout the world has been carried out by the European consortium Exscalate4CoV, an organism that has focused its efforts on verifying the “potential impact of already known molecules against the genomic structure of the coronavirus”.
As reported by the European Commission, The promising preliminary results obtained by the aforementioned consortium have been achieved after virtually testing “400,000 molecules using their supercomputers.” This scientific institution, which has 18 partners and 15 associate members, including the National Supercomputing Center, located in Barcelona, preselected 7,000 of these molecules. Of these, 40 were active in the experiments, with Raloxifene being the most effective.Stops the progression of the disease
The conclusion that the researchers have reached in the initial tests is that This medicine could be apt to block the replication of the virus in the cells, thus slowing down the progression of the disease, especially in its earliest phases, without producing any negative reaction in the patient.
However, the investigation still has to face more tests to confirm its results. If, as they hope, the European Medicines Agency authorizes “the potential use” of the drug in patients with coronavirus, it “could quickly be made available to the public in large quantities and at low cost”, according to those responsible for the study.
News Source: cvbj.biz
EU threatens escalation in tariff fight over Boeing and Airbus subsidies
The EU says it will act "decisively" if the US goes ahead with a threat to put new tariffs on its goods.
It is latest twist in a long-running row with Washington over subsidies granted to the planemaker Airbus.
For more than a decade, the EU and US have accused each other of propping up their home aviation markets with tax breaks, research grants and other aid.
Last month, the US threatened duties on EU goods such as beer, gin and olives, escalating the row.
On Monday, Europe's trade commissioner Phil Hogan said Washington had rejected moves to settle the dispute.
"I want to reassure people that we are ready to act decisively and strongly on the European Union side if we don't get the type of outcome that we expect from the United States in relationship to finalising this 15-year-old dispute," he told the European Parliament's trade committee.Image copyright Reuters Image caption European Trade Commissioner Phil Hogan said the EU will act "decisively and strongly"
The World Trade Organization (WTO) has already ruled that subsidies given by the EU to Airbus in 2004 were illegal.
However, it is also considering a parallel case involving illegal support for US aerospace firm Boeing, which could see the EU impose duties on Washington later this year.
In line with the WTO ruling, the US has already imposed tariffs of 15-25% on $7.5bn (£6bn) worth of European goods.
But last month, the US said it was considering new taxes on additional EU trade worth $3.1bn annually - a move described as excessive by Brussels.
- US threatens tariffs on EU beer, gin and olives
- Tariffs to increase on aircraft after subsidy row
On Monday, Mr Hogan also criticised recent national security investigations launched by the US against EU goods, which are also considered to be further retaliation.
The investigations, known as 232 investigations, cover products from transformers and mobile cranes to steel nails.
"It's not appreciated the number of 232 investigations that have been launched in recent weeks, perhaps this is political, perhaps it's more real," Mr Hogan said.
"This is totally unacceptable," he said. "If these investigations go further, the European Union will have to stand together and act as well."
The US is also involved in other trade spats with the EU.
Before last year's tariffs over Airbus, the Trump administration had imposed duties on EU steel and aluminium - spurring Brussels to tax iconic US products such as denim jeans and motorcycles.
Mr Trump has also threatened duties on European cars, a particular concern to Germany.Related Topics
- Trump tariffs
- Airbus Group